Search Clinical Trials
597,783 trials
ID
Status
Phase
Title
Sponsor
NCT07758348
Investigating Modulation of Neuropathic Pain by Transcranial Magnetic Stimulation: a Multimodal Imaging and Electrophysiological ApproachNational Taiwan University HospitalNot Yet RecruitingNot Applicable
NCT07758348Not Yet Recruiting
Not Applicable
Investigating Modulation of Neuropathic Pain by Transcranial Magnetic Stimulatio...National Taiwan Universit...
NCT07756801
CAPITAL OFFLOAD-SHOCKOttawa Heart Institute Research CorporationNot Yet RecruitingPhase 4
NCT07757087
A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Obesity, Compared to a Low-calorie Diet or PlaceboNovo Nordisk A/SRecruitingPhase 1
NCT07757087Recruiting
Phase 1
A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a W...Novo Nordisk A/S
NCT07758790
A Registry Study to Assess SYNTHECELTM Dura RepairDePuy Synthes Products, Inc.Not Yet Recruiting
NCT07758790Not Yet Recruiting
—
A Registry Study to Assess SYNTHECELTM Dura RepairDePuy Synthes Products, I...
NCT07757802
Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy AdultsNational Institute of Allergy and Infectious Diseases (NIAID)Not Yet RecruitingPhase 1
NCT07757802Not Yet Recruiting
Phase 1
Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Ad...National Institute of All...
NCT07757334
Trauma-Focused Group Therapy for Adults With Trauma-Related Symptoms in Primary CareFundació Vidal i BarraquerNot Yet RecruitingNot Applicable
NCT07757334Not Yet Recruiting
Not Applicable
Trauma-Focused Group Therapy for Adults With Trauma-Related Symptoms in Primary...Fundació Vidal i Barraque...
NCT07758816
Advancing Integrated Therapies for Gaucher DiseaseSanofi-Yale External Research CollaborationRecruiting
NCT07758816Recruiting
—
Advancing Integrated Therapies for Gaucher DiseaseSanofi-Yale External Rese...
NCT07757178
Lived Experience Narratives in DementiaNottinghamshire Healthcare NHS TrustRecruitingNot Applicable
NCT07757178Recruiting
Not Applicable
Lived Experience Narratives in DementiaNottinghamshire Healthcar...
NCT07757607
A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Base for MRace as a Treatment Option for FMR Patients With Complex M-TEER Anatomies (FR)Polares Medical SANot Yet RecruitingNot Applicable
NCT07757607Not Yet Recruiting
Not Applicable
A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Ba...Polares Medical SA
NCT07757685
Autologous Hematopoietic Stem Cell Transplantation for Neurological Damage Associated With Hereditary Homocysteine Remethylation DisordersInstitute of Hematology & Blood Diseases Hospital, ChinaNot Yet RecruitingNot Applicable
NCT07757685Not Yet Recruiting
Not Applicable
Autologous Hematopoietic Stem Cell Transplantation for Neurological Damage Assoc...Institute of Hematology &...
NCT07758881
A Prospective Study Evaluating the Safety and Performance of the Eight Medical Hyperthermia System IV 1.0 for HIVEC in NMIBC.Eight Medical International BVNot Yet RecruitingNot Applicable
NCT07758881Not Yet Recruiting
Not Applicable
A Prospective Study Evaluating the Safety and Performance of the Eight Medical H...Eight Medical Internation...
NCT07758075
A Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1139 Injection in Patients With Plaque PsoriasisGuangdong Hengrui Pharmaceutical Co., LtdNot Yet RecruitingPhase 2
NCT07758075Not Yet Recruiting
Phase 2
A Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1139 Inject...Guangdong Hengrui Pharmac...
NCT07758985
Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner in Healthy Participants in Mali.London School of Hygiene and Tropical MedicineNot Yet RecruitingPhase 1
NCT07758985Not Yet Recruiting
Phase 1
Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner...London School of Hygiene...
NCT07757100
High-Intensity Interval Training Effects on Fitness in Youth Soccer PlayersErcüment ErdoğanCompletedNot Applicable
NCT07757100Completed
Not Applicable
High-Intensity Interval Training Effects on Fitness in Youth Soccer PlayersErcüment Erdoğan
NCT07756814
Manual Intervention and Congenital Hip Dysplasia in InfantsUniversité de SherbrookeNot Yet RecruitingNot Applicable
NCT07756814Not Yet Recruiting
Not Applicable
Manual Intervention and Congenital Hip Dysplasia in InfantsUniversité de Sherbrooke
NCT07758634
A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With HypertensionCRISPR Therapeutics AGRecruitingPhase 1
NCT07758634Recruiting
Phase 1
A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants W...CRISPR Therapeutics AG
NCT07758478
Montessori-Based Interventions for Older AdultsGazi UniversityNot Yet RecruitingNot Applicable
NCT07758478Not Yet Recruiting
Not Applicable
Montessori-Based Interventions for Older AdultsGazi University
NCT07758998
The Effect of Motivational Interviewing on Smoking Behavior Among Nursing StudentsMeral Feratoğlu ResearchNot Yet RecruitingNot Applicable
NCT07758998Not Yet Recruiting
Not Applicable
The Effect of Motivational Interviewing on Smoking Behavior Among Nursing Studen...Meral Feratoğlu Research
NCT07758595
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in Healthy Participants and Participants With Alzheimer's DiseaseDenali Therapeutics Inc.Not Yet RecruitingPhase 1
NCT07758595Not Yet Recruiting
Phase 1
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921...Denali Therapeutics Inc.
NCT07757113
Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergoing Middle Meningeal Artery (MMA) Embolizationphenox Inc.Not Yet RecruitingNot Applicable
NCT07757113Not Yet Recruiting
Not Applicable
Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergo...phenox Inc.
Result Breakdown
Not yet recruiting15 (75%)
Recruiting4 (20%)
Completed1 (5%)
not_applicable11 (55%)
Phase 15 (25%)
Not Specified2 (10%)
Phase 41 (5%)
Phase 21 (5%)